REFERENCES

1. Bruner LP, White AM, Proksell S. Inflammatory bowel disease. Prim Care. 2023;50:411-27.

2. Levine A, Koletzko S, Turner D, et al. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58:795-806.

3. Hracs L, Windsor JW, Gorospe J, et al. ; Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) Research Group. Global evolution of inflammatory bowel disease across epidemiologic stages. Nature. 2025;642:458-66.

4. GBD 2017 Inflammatory Bowel Disease Collaborators. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5:17-30.

5. Gros B, Kaplan GG. Ulcerative colitis in adults: a review. JAMA. 2023;330:951-65.

6. Larmonier CB, Shehab KW, Ghishan FK, Kiela PR. T lymphocyte dynamics in inflammatory bowel diseases: role of the microbiome. Biomed Res Int. 2015;2015:504638.

7. Sznurkowska K. T regulatory cells in inflammatory bowel disease—are they major players? Int J Mol Sci. 2025;26:11944.

8. Mahdy AKH, Elabd H, Kokubun ÉE, et al.; IBSEN-III study group. Multi-centered T cell repertoire profiling identifies alterations in the immune repertoire of individuals with inflammatory bowel disease across different disease stages. Genome Med. 2026;18:3.

9. Rosati E, Rios Martini G, Pogorelyy MV, et al. A novel unconventional T cell population enriched in Crohn’s disease. Gut. 2022;71:2194-204.

10. Minervina AA, Pogorelyy MV, Paysen S, et al. Crohn’s-associated invariant T cells (CAITs) recognise small sulfonate molecules on CD1d. Gut. 2023;73:205-6.

11. Wands DIF, Gianolio L, Cameron F, Hansen R, Russell RK, Wilson DC. Pediatric inflammatory bowel disease type unclassified: a nationwide cohort study in scotland with up to 20 years follow-up shows reclassification in the majority and mild course in those whose diagnosis is unchanged. Inflamm Bowel Dis. 2025;31:313-20.

12. Müller F, Atreya R, Völkl S, et al. CD19 CAR T-cell therapy in multidrug-resistant ulcerative colitis. N Engl J Med. 2025;393:1239-41.

13. Mitsialis V, Wall S, Liu P, et al. Single-cell analyses of colon and blood reveal distinct immune cell signatures of ulcerative colitis and Crohn’s disease. Gastroenterology. 2020;159:591-608.e10.